FCRL3 gene polymorphisms as risk factors for rheumatoid arthritis

Human Immunology

Volumn 77, Issue 2, 2016, Pages 223-229

  Lin, Xin ^a   Zhang, Yi ^a   Chen, Qinghe ^a  

^a FUJIAN PROVINCIAL HOSPITAL   (China)

Author keywords

Anti cyclic citrullinated peptide antibody (ACPA); Fc receptor like 3 (FCRL3); Rheumatoid arthritis (RA); Rheumatoid factor (RF); Single nucleotide polymorphism (SNP)

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FC RECEPTOR; FC RECEPTOR LIKE 3; RHEUMATOID FACTOR; UNCLASSIFIED DRUG; FCRL3 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HIGH RISK PATIENT; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHINA; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; META ANALYSIS; MIDDLE AGED;

ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; RISK FACTORS;

EID: 84958117729     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2015.12.007     Document Type: Article

References (42)

1. Lee D.M., Weinblatt M.E. Rheumatoid arthritis. Lancet 2001, 358:903-911.
2. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
3. MacGregor A.J., Snieder H., Rigby A.S., Koskenvuo M., Kaprio J., et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000, 43:30-37.
4. Gregersen P.K., Silver J., Winchester R.J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987, 30:1205-1213.
5. Plenge R.M., Seielstad M., Padyukov L., Lee A.T., Remmers E.F., et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N. Engl. J. Med. 2007, 357:1199-1209.
6. Plenge R.M., Cotsapas C., Davies L., Price A.L., de Bakker P.I., et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat. Genet. 2007, 39:1477-1482.
7. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med. 2007, 357:977-986.
8. Shimane K., Kochi Y., Horita T., Ikari K., Amano H., et al. The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population. Arthritis Rheum. 2010, 62:574-579.
9. Zhang Z.H., Chen F., Zhang X.L., Jin Y., Bai J., et al. PTPN22 allele polymorphisms in 15 Chinese populations. Int. J. Immunogenet. 2008, 35:433-437.
10. Davis R.S., Wang Y.H., Kubagawa H., Cooper M.D. Identification of a family of Fc receptor homologs with preferential B cell expression. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:9772-9777.
11. Chistiakov D.A., Chistiakov A.P. Is FCRL3 a new general autoimmunity gene?. Hum. Immunol. 2007, 68:375-383.
12. Kochi Y., Yamada R., Suzuki A., Harley J.B., Shirasawa S., et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat. Genet. 2005, 37:478-485.
13. Wu H., Yang L.H., Zuo J., Liang Y.L., Li P.Q., et al. Fc receptor-like 3 gene polymorphisms confer susceptibility to rheumatoid arthritis in a Chinese population. Hum. Immunol. 2010, 71:1203-1208.
14. Hu X., Chang M., Saiki R.K., Cargill M.A., Begovich A.B., et al. The functional -169T->C single-nucleotide polymorphism in FCRL3 is not associated with rheumatoid arthritis in white North Americans. Arthritis Rheum. 2006, 54:1022-1025.
15. Hou S., Kijlstra A., Yang P. The genetics of Behcet's disease in a Chinese population. Front. Med. 2012, 6:354-359.
16. Duchatelet S., Caillat-Zucman S., Dubois-Laforgue D., Blanc H., Timsit J., et al. FCRL3 -169CT functional polymorphism in type 1 diabetes and autoimmunity traits. Biomed. Pharmacother. 2008, 62:153-157.
17. Sang D., Chen Q., Liu X., Qu H., Wei D., et al. Fc receptor like 3 in Chinese patients of Han nationality with Guillain-Barre syndrome. J. Neuroimmunol. 2012, 246:65-68.
18. Choi C.B., Kang C.P., Seong S.S., Bae S.C., Kang C. The -169C/T polymorphism in FCRL3 is not associated with susceptibility to rheumatoid arthritis or systemic lupus erythematosus in a case-control study of Koreans. Arthritis Rheum. 2006, 54:3838-3841.
19. Ikari K., Momohara S., Nakamura T., Hara M., Yamanaka H., et al. Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis. Ann. Rheum. Dis. 2006, 65:671-673.
20. Thabet M.M., Wesoly J., Slagboom P.E., Toes R.E., Huizinga T.W. FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians. Ann. Rheum. Dis. 2007, 66:803-806.
21. Newman W.G., Zhang Q., Liu X., Walker E., Ternan H., et al. Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population. Arthritis Rheum. 2006, 54:3820-3827.
22. Watanabe Y., Nunokawa A., Kaneko N., Muratake T., Arinami T., et al. Two-stage case-control association study of polymorphisms in rheumatoid arthritis susceptibility genes with schizophrenia. J. Hum. Genet. 2009, 54:62-65.
23. Takata Y., Inoue H., Sato A., Tsugawa K., Miyatake K., et al. Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: results of an independent Japanese population and evidence from meta-analysis of East Asian studies. J. Hum. Genet. 2008, 53:163-173.
24. Lalitha S. Biotech software & internet report. Comput. Softw. J. Sci. 2000, 1:270-272.
25. SPSS IBM SPSS Statistics 22.0 Command Syntax Reference 2013, SPSS Inc.
26. Motulsky H.J. Prism 4 Statistics Guide-Statistical Analyses for Laboratory and Clinical Researchers 2003, GraphPad Software Inc., San Diego, CA, (p. 122).
27. Chen J.Y., Wang C.M., Wu Y.J., Kuo S.N., Shiu C.F., et al. Disease phenotypes and gender association of FCRL3 single-nucleotide polymorphism -169T/C in Taiwanese patients with systemic lupus erythematosus and rheumatoid arthritis. J. Rheumatol. 2011, 38:264-270.
28. Eike M.C., Nordang G.B., Karlsen T.H., Boberg K.M., Vatn M.H., et al. The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases. Ann. Rheum. Dis. 2008, 67:1287-1291.
29. El-Gabalawy H.S., Robinson D.B., Daha N.A., Oen K.G., Smolik I., et al. Non-HLA genes modulate the risk of rheumatoid arthritis associated with HLA-DRB1 in a susceptible North American Native population. Genes Immun. 2011, 12:568-574.
30. Eyre S., Bowes J., Potter C., Worthington J., Barton A. Association of the FCRL3 gene with rheumatoid arthritis: a further example of population specificity?. Arthritis Res. Ther. 2006, 8:R117.
31. Golmoghaddam H., Amirghofran Z., Aflaki E., Kamali-Sarvestani E., Shabani M., et al. Association of FCRL3 genotypes with susceptibility of Iranian patients to rheumatoid arthritis. Immunol. Invest. 2013, 42:296-306.
32. Martinez A., Sanchez E., Valdivia A., Orozco G., Lopez-Nevot M.A., et al. Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis. Ann. Rheum. Dis. 2006, 65:1188-1191.
33. Owen C.J., Kelly H., Eden J.A., Merriman M.E., Pearce S.H., et al. Analysis of the Fc receptor-like-(FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J. Clin. Endocrinol. Metab. 2007, 92:1106-1111.
34. Davis R.S. Fc receptor-like molecules. Annu. Rev. Immunol. 2007, 25:525-560.
35. Gibson A.W., Li F.J., Wu J., Edberg J.C., Su K., et al. The FCRL3 -169CT promoter single-nucleotide polymorphism, which is associated with systemic lupus erythematosus in a Japanese population, predicts expression of receptor protein on CD19+ B cells. Arthritis Rheum. 2009, 60:3510-3512.
36. Smyth D.J., Howson J.M., Payne F., Maier L.M., Bailey R., et al. Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases. BMC Med. Genet. 2006, 7:20.
37. Piotrowski P., Lianeri M., Prokop E., Wudarski M., Olesinska M., et al. The FCRL3 -169T>C polymorphism might be associated with some autoantibody presence in patients with SLE in a Polish population. Mod. Rheumatol. 2014, 24:296-299.
38. Inoue N., Watanabe M., Yamada H., Takemura K., Hayashi F., et al. Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies. J. Clin. Immunol. 2012, 32:1243-1252.
39. Kochi Y., Suzuki A., Yamada R., Yamamoto K. Ethnogenetic heterogeneity of rheumatoid arthritis -implications for pathogenesis. Nat. Rev. Rheumatol. 2010, 6:290-295.
40. Burmester G.R., Feist E., Dorner T. Emerging cell and cytokine targets in rheumatoid arthritis. Nat. Rev. Rheumatol. 2014, 10:77-88.
41. Maehlen M.T., Nordang G.B., Syversen S.W., van der Heijde D.M., Kvien T.K., et al. FCRL3 -169C/C genotype is associated with anti-citrullinated protein antibody-positive rheumatoid arthritis and with radiographic progression. J. Rheumatol. 2011, 38:2329-2335.
42. Ramirez-Bello J., Jimenez-Morales S., Espinosa-Rosales F., Gomez-Vera J., Gutierrez A., et al. Juvenile rheumatoid arthritis and asthma, but not childhood-onset systemic lupus erythematosus are associated with FCRL3 polymorphisms in Mexicans. Mol. Immunol. 2013, 53:374-378.